Sol J. Barer, Director at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), bought 104,500 shares at $9.60 ($1.0M) on 2019-06-04, disclosed to the SEC on 2019-06-05.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| NEXI | BUY | 2022-06-02 | $312K | — | Filing → |
| NEXI | BUY | 2022-03-24 | $27K | — | Filing → |
| NEXI | BUY | 2022-03-23 | $72K | — | Filing → |